Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarenflurbil in Localized Prostate Cancer with Rising PSA
NCT00045123Phase 2Unknown
- Sponsor
- Myrexis, Inc.
- Start
- Feb 2002
- Countries
- 1
01
Overview
A Phase 2 trial of tarenflurbil in prostate cancer (PCa), sponsored by Myrexis, Inc.. Status: unknown.
02
Drugs
tarenflurbil
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00045123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045123.